How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and Canada

Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and Canada. Health Policy, 126 (11). 1130 - 1143. ISSN 0168-8510

Text (Kanavos_how-do-hta-agencies-perceive--published) - Published Version Available under License Creative Commons Attribution. Download (1MB)

• Author

Abstract

There is a growing disconnect between regulatory agencies that are promoting expedited approval to medicines based on early phase clinical evidence and health technology assessment (HTA) agencies that require robust clinical evidence to inform coverage decisions. This paper provides an assessment of the evidence gap between regulatory and HTA agencies on medicines receiving conditional marketing authorisation (MA) and examines how HTA agencies in France, England, Scotland, and Canada interpret and appraise evidence for these medicines. A mixed methods research design was used to identify the types and frequency of parameters raised in the context of HTA decision-making for all conditional approvals in Europe and Canada between 2010-2017. Significant heterogeneity was found across the HTA agencies in England, Scotland, France, and Canada in the assessment of medicines receiving conditional MA, with the highest likelihood of rejection present in Quebec (50%) and Scotland (25%). Rejected medicines were more likely to have unresolved uncertainties related to the magnitude of clinical benefit, study design, and issues in economic modelling. More systematic use of joint early dialogue and conditional reimbursement pathways would help clarify evidence requirements and avoid delays in patient access to innovative medicines.

Item Type:	Article
Official URL:	https://www.sciencedirect.com/journal/health-polic...
Additional Information:	© 2022 The Author(s).
Divisions:	Health Policy
Subjects:	R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Date Deposited:	24 Aug 2022 09:51
Last Modified:	16 Nov 2024 21:12
URI:	http://eprints.lse.ac.uk/id/eprint/116379

Actions (login required)

View Item